HomeAI · summaries
Storia in 2 fonti
After FDA sign-off, Colorado's drug import plan faces tough road ahead
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own hands, albeit through a framework that may be difficult to pull off i | Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own hands, albeit through a framework that may be difficult to pull off in the real world.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
Of the 400 million patients worldwide diagnosed with rare diseases, about 250 million of them live in North and Southeast Asia1. | While the demand in Asia-Pacific clearly exists,…
- ·
How lab data powers precision commercialization to drive therapy adoption
Drug commercialization depends on reaching the right physicians at the right moment. | Drug commercialization depends on reaching the right physicians at the right moment.
